Search for: [Abstract = "n among the HFpEF patients. MRAs and beta\-blockers were less frequently administered to HFpEF patients in comparison to those with HFmrEF and HFrEF. Patients affected by HFpEF received calcium channel blockers significantly more often. Antiplatelet medications were significantly less often used in the HFpEF group, while anticoagulants were significantly more often administered to HFpEF patients in comparison to participants with other HF types. The group of patients HFmrEF fell between the patients with HFrEF and HFpEF, although with some exceptions. Myocardial infarction constituted the most frequent cause of hospitalisation in comparison with HFrEF and HFpEF patients\; this group prevailed among outpatients. Ischemic heart disease was listed among most common causes. Prior myocardial infarction\/ischemic heart disease constituted the prevalent comorbidities. CABG procedure was completed most often within this group. Furosemide was significantly less often administered to the patients with HFmrEF, with antiplatelet medication being used more frequently. CONCLUSIONS 1. The characteristics of the Polish population of patients included in the Heart Failure Long Term Registry varied depending on the type of heart failure in terms of demographic data, etiology, comorbidities, risk factors, physical examination, some laboratory parameters, electrocardiographic and echocardiographi"]
